Has Jacqueline Dowe, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,170 in general payments to Jacqueline Dowe, MD across 399 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jacqueline Dowe, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jacqueline Dowe, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jacqueline Dowe, MD

Advanced Heart Failure and Transplant Cardiology · Orlando, FLNPI 1992952501

Payments from drug & device makers

$7,170in general payments, 2019–2025

Across 399 payments — averaging $17.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$1K
Amgen$640
Johnson & Johnson$606
AstraZeneca$595
Pfizer$474
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$449
plus $3K from 47 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	74	$1,013
Amgen	43	$640
Johnson & Johnson	47	$606
AstraZeneca(2 entities)	17	$595
Pfizer	30	$474
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	26	$449
Alnylam Pharmaceuticals Inc.	7	$251
Grifols USA, LLC	16	$250
Abiomed	2	$238
Actelion Pharmaceuticals US, Inc.	10	$236
Amarin Pharma, Inc.	14	$220
Cvrx, Inc.	6	$217
E.r. Squibb & Sons, L.L.C.	6	$180
Abbott	7	$160
Philips North America LLC	11	$159
Medtronic	4	$141
Scpharmaceuticals Inc.	4	$108
Chiesi USA, Inc.	7	$104
Boehringer Ingelheim	6	$92
Merck	7	$89
Sanofi-aventis U.S. LLC	5	$83
Esperion Therapeutics, Inc.	5	$81
Novo Nordisk	4	$57
Kiniksa Pharmaceuticals, Ltd.	3	$50
Bridgebio Pharma, Inc.	2	$49
Kestra Medical Technology Services, Inc.	2	$44
Kiniksa Pharmaceuticals International, PLC	2	$41
Mallinckrodt Hospital Products Inc.	2	$41
Shockwave Medical, Inc	2	$40
Akcea Therapeutics, Inc.	3	$37
Kowa Pharmaceuticals America, Inc.	2	$31
Mayne Pharma Commercial LLC	1	$28
Bayer	1	$24
Amryt Pharma Holdings Ltd	2	$24
Axsome Therapeutics, Inc.	1	$23
Biotronik Inc.	1	$23
Regeneron Healthcare Solutions, Inc.	1	$22
Sunovion Pharmaceuticals Inc.	1	$20
Bracco Diagnostics Inc.	1	$20
Portola Pharmaceuticals, LLC	1	$19
Livanova USA, Inc.	1	$18
Mylan Specialty L.p.	1	$17
Lilly USA, LLC	1	$17
Boston Scientific	1	$17
Inari Medical, Inc.	1	$15
Altathera Pharmaceuticals LLC	1	$15
Teva Pharmaceuticals USA, Inc.	1	$15
Lundbeck LLC	1	$14
Baxter Healthcare	1	$13
Siemens Medical Solutions USA, Inc.	1	$13
Electromed, Inc.	1	$13
Otsuka America Pharmaceutical, Inc.	1	$13
Braemar Manufacturing, LLC	1	$11

How this compares

$7,170 in reported general payments places this provider in the 40th percentile of 48 advanced heart failure and transplant cardiology providers in Florida.

See all advanced heart failure and transplant cardiology providers in Florida →

Medicare billing

Part B allowed, 2024

$95,810

Medicare patients

404

Services billed

1,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Orlando

Stacy MandrasOrlando$959K
Andrija VidicOrlando$449K
Naveen BellamOrlando$414K
Pujan PatelOrlando$66K
Sula MazimbaOrlando$61K
Mauricio VelezOrlando$39K
Shahid QamarOrlando$38K
Sushma KoneruOrlando$26K
Akanksha AgrawalOrlando$5K
Krithika KrishnaraoOrlando$4K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →